DEF 14A

Company

Lexaria Bioscience Corp.

Filed

May 14, 2021

Period of Report

May 3, 2021

Accession Number

0001640334-21-001147

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →